Department of Medical Oncology
Ronny Drapkin has not added Biography.
If you are Ronny Drapkin and would like to personalize this page please email our Author Liaison for assistance.
BRCA1 supports XIST RNA concentration on the inactive X chromosome.
Cell Nov, 2002 | Pubmed ID: 12419249
The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.
Cell May, 2003 | Pubmed ID: 12732143
Unilateral transverse arm defect with subterminal digital nubbins.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society Jul-Aug, 2003 | Pubmed ID: 14692649
The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2004 | Pubmed ID: 14983014
Association of BRCA1 with the inactive X chromosome and XIST RNA.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences Jan, 2004 | Pubmed ID: 15065664
Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
Human pathology Aug, 2004 | Pubmed ID: 15297969
Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing.
Genes & development Feb, 2005 | Pubmed ID: 15713842
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Cancer research Mar, 2005 | Pubmed ID: 15781627
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Current opinion in obstetrics & gynecology Feb, 2007 | Pubmed ID: 17218844
A recurrent mutation in PALB2 in Finnish cancer families.
Nature Mar, 2007 | Pubmed ID: 17287723
Further evidence for BRCA1 communication with the inactive X chromosome.
Cell Mar, 2007 | Pubmed ID: 17350581
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
Clinical medicine & research Mar, 2007 | Pubmed ID: 17456833
Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications.
The American journal of surgical pathology May, 2007 | Pubmed ID: 17460458
Serous carcinogenesis in the fallopian tube: a descriptive classification.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists Jan, 2008 | Pubmed ID: 18156967
A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Gastroenterology Feb, 2008 | Pubmed ID: 18242217
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
Gynecologic oncology May, 2008 | Pubmed ID: 18342932
Does the fimbria have an embryologic origin distinct from that of the rest of the fallopian tube?
Fertility and sterility Nov, 2008 | Pubmed ID: 18353321
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2008 | Pubmed ID: 18451228
Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists Jul, 2008 | Pubmed ID: 18580316
A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2008 | Pubmed ID: 18628483
Urokinase-type plasminogen activator receptor: a beacon of malignancy?
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2008 | Pubmed ID: 18794069
New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2008 | Pubmed ID: 18854563
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2008 | Pubmed ID: 18927287
Ovarian cancer pathogenesis: a model in evolution.
Journal of oncology , 2010 | Pubmed ID: 19746182
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
Histopathology Nov, 2009 | Pubmed ID: 19912369
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
Neoplasia (New York, N.Y.) Feb, 2010 | Pubmed ID: 20126474
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells.
Cancer cell Mar, 2010 | Pubmed ID: 20227043
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
The American journal of surgical pathology May, 2010 | Pubmed ID: 20414098
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.
Nature structural & molecular biology Jun, 2010 | Pubmed ID: 20453858
STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis.
Frontiers in bioscience (Elite edition) , 2011 | Pubmed ID: 21196340
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
Proceedings of the National Academy of Sciences of the United States of America May, 2011 | Pubmed ID: 21502498
A comprehensive analysis of PAX8 expression in human epithelial tumors.
The American journal of surgical pathology Jun, 2011 | Pubmed ID: 21552115
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.
Gynecologic oncology Oct, 2011 | Pubmed ID: 21683992
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2011 | Pubmed ID: 21746896
Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.
The American journal of surgical pathology Oct, 2011 | Pubmed ID: 21921781
High throughput interrogation of somatic mutations in high grade serous cancer of the ovary.
PloS one , 2011 | Pubmed ID: 21931712
Rethinking ovarian cancer: recommendations for improving outcomes.
Nature reviews. Cancer Oct, 2011 | Pubmed ID: 21941283
The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer.
Gynecologic oncology Feb, 2012 | Pubmed ID: 22019526
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy.
Science (New York, N.Y.) Nov, 2011 | Pubmed ID: 22033517
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.
Gynecologic oncology Feb, 2012 | Pubmed ID: 22037318
The new face of ovarian cancer modeling: better prospects for detection and treatment.
F1000 medicine reports , 2011 | Pubmed ID: 22076125
ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers.
PloS one , 2012 | Pubmed ID: 22279592
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados